Skip to main content

Novel clinical evidence in continuous glucose monitoring

03-01-2023 | Continuous glucose monitoring | Video

How real-world studies complement randomized controlled trials

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials (15:10).

Jean-Pierre Riveline

Jean-Pierre Riveline is Professor of Endocrinology and Diabetology at Lariboisière Hospital in Paris, France. He is responsible for the University Center for Diabetes and its Complications (CUDC).


  • Advisory panel member for: Sanofi, MSD, Eli Lilly, Novo Nordisk, AstraZeneca, Abbott, Dexcom, Alphadiab, Insulet and Medtronic.
  • Research funding and research support: Abbott, Insulet, Medtronic, Air Liquide, Sanofi, Roche and Novo Nordisk.

Full biography